USE OF DG153 SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME

Title:

USE OF DG153 SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME

Document Type and Number:

WIPO Patent Application WO2005005471

Kind Code:

A3

Abstract:

The present invention discloses proteins secreted by the developing pancreas, and polynucleotides, which identify and encode these proteins. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.

Inventors:

ONICHTCHOUK DARIA (DE)

Application Number:

PCT/EP2004/007531

Publication Date:

June 23, 2005

Filing Date:

July 08, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

DEVELOGEN AG (DE)
ONICHTCHOUK DARIA (DE)

International Classes:

A61K38/17; A61P3/00; C07K14/475; (IPC1-7): C07K14/435; A61K38/17; A61P3/00

Domestic Patent References:

WO2002074956A2	2002-09-26
WO2001019851A2	2001-03-22
WO2002079246A2	2002-10-10

Foreign References:

US20020132978A1

2002-09-19

Other References:

SHRIDHAR V ET AL: "Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer.", ONCOGENE. 8 MAY 1997, vol. 14, no. 18, 8 May 1997 (1997-05-08), pages 2213 - 2216, XP001204720, ISSN: 0950-9232

Download PDF:

View/Download PDF PDF Help

Previous Patent: PECTIN METHYLESTERASE INHIBITORS FOR THE PREPARATION OF FRUIT JUICES AND DERIVATIVES

Next Patent: METHODS TO MODULATE THE ACTIVITY OF THE OESTROGEN RECEPTOR